Objectives and Outcomes

GenomALC Consortium aims to identify genetic risk factors that predispose some drinkers to Alcoholic Liver Cirrhosis (ALC).

Significant outcomes will be:

  • Creation of GenomALC Consortium dedicated towards research on alcoholic liver cirrhosis
  • Creation of a large database with defined phenotypes and genotypes
  • Foundation of the first genetic architecture of ALC
  • Identification of genetic risk variants and their clinical correlates
  • Genetic biomarkers to help in strategies for treatment of ALC